TrialRheumatology (Oxford, England)2022

Ixekizumab in radiographic axial spondyloarthritis with and without elevated C-reactive protein or positive magnetic resonance imaging.

Walter P Maksymowych et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.